Search research articles
Contact Us
Filters
Showing results (11-20 of 79) with videos related to
Page
of 8
Sort By:
International Journal of Antimicrobial Agents
|
May 14, 2013
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance
Jakko van Ingen, Wouter Hoefsloot, Johan W Mouton, et al.
Respiratory Medicine
|
September 27, 2017
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort
Sanne Zweijpfenning, Stephan Kops, Cecile Magis-Escurra, et al.
Respiratory Investigation
|
August 2, 2025
The spectrum of CFTR dysfunction in patients with nontuberculous mycobacterial pulmonary disease
Arthur Lemson, Monique Reijers, Dineke Westra, et al.
Journal of Bronchology & Interventional Pulmonology
|
July 11, 2020
Cone-Beam CT Image Guidance With and Without Electromagnetic Navigation Bronchoscopy for Biopsy of Peripheral Pulmonary Lesions
Roel L J Verhoeven, Jurgen J Fütterer, Wouter Hoefsloot, et al.
The Journal of Antimicrobial Chemotherapy
|
November 10, 2025
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system
Jelmer Raaijmakers, Rob Aarnoutse, Lindsey Te Brake, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2023
The role of rifampicin within the treatment of <i>Mycobacterium avium</i> pulmonary disease
Jodie A Schildkraut, Jelmer Raaijmakers, Rob Aarnoutse, et al.
Journal of Clinical Microbiology
|
February 15, 2019
Implementation of Semiautomated Antimicrobial Susceptibility Interpretation Hardware for Nontuberculous Mycobacteria May Overestimate Susceptibility
Mariëlle Rockland, Mike Marvin Ruth, Nicole Aalders, et al.
Expert Review of Respiratory Medicine
|
October 3, 2017
Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives
Lars-Olof Larsson, Eva Polverino, Wouter Hoefsloot, et al.
Expert Review of Respiratory Medicine
|
March 21, 2025
Treatment of nontuberculous mycobacterial pulmonary disease requires a stepwise and multidisciplinary approach
Arthur Lemson, Arjan van Laarhoven, Lisa Kurver, et al.
Respiratory Research
|
April 8, 2015
High definition bronchoscopy: a randomized exploratory study of diagnostic value compared to standard white light bronchoscopy and autofluorescence bronchoscopy
Erik H F M van der Heijden, Wouter Hoefsloot, Hieronymus W H van Hees, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 79) with videos related to
Sort By:
Page
of 8
International Journal of Antimicrobial Agents
|
May 14, 2013
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance
Jakko van Ingen, Wouter Hoefsloot, Johan W Mouton, et al.
Respiratory Medicine
|
September 27, 2017
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort
Sanne Zweijpfenning, Stephan Kops, Cecile Magis-Escurra, et al.
Respiratory Investigation
|
August 2, 2025
The spectrum of CFTR dysfunction in patients with nontuberculous mycobacterial pulmonary disease
Arthur Lemson, Monique Reijers, Dineke Westra, et al.
Journal of Bronchology & Interventional Pulmonology
|
July 11, 2020
Cone-Beam CT Image Guidance With and Without Electromagnetic Navigation Bronchoscopy for Biopsy of Peripheral Pulmonary Lesions
Roel L J Verhoeven, Jurgen J Fütterer, Wouter Hoefsloot, et al.
The Journal of Antimicrobial Chemotherapy
|
November 10, 2025
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system
Jelmer Raaijmakers, Rob Aarnoutse, Lindsey Te Brake, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2023
The role of rifampicin within the treatment of <i>Mycobacterium avium</i> pulmonary disease
Jodie A Schildkraut, Jelmer Raaijmakers, Rob Aarnoutse, et al.
Journal of Clinical Microbiology
|
February 15, 2019
Implementation of Semiautomated Antimicrobial Susceptibility Interpretation Hardware for Nontuberculous Mycobacteria May Overestimate Susceptibility
Mariëlle Rockland, Mike Marvin Ruth, Nicole Aalders, et al.
Expert Review of Respiratory Medicine
|
October 3, 2017
Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives
Lars-Olof Larsson, Eva Polverino, Wouter Hoefsloot, et al.
Expert Review of Respiratory Medicine
|
March 21, 2025
Treatment of nontuberculous mycobacterial pulmonary disease requires a stepwise and multidisciplinary approach
Arthur Lemson, Arjan van Laarhoven, Lisa Kurver, et al.
Respiratory Research
|
April 8, 2015
High definition bronchoscopy: a randomized exploratory study of diagnostic value compared to standard white light bronchoscopy and autofluorescence bronchoscopy
Erik H F M van der Heijden, Wouter Hoefsloot, Hieronymus W H van Hees, et al.
Page
of 8